The above research shows that the Nrf2/HO-1 axis has a bidirectional regulation function in the ferroptosis of CRC, which can be used as a pharmacological target of colorectal cancer and provide a new direction for the choice of future treatment strategies. This evidence concerns the gene HMOX1 and colorectal carcinoma.